Latest news
Loading news…
Kairos Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Vancouver, British Columbia, Canada Founded 2013 51-100 employees For Profit
Kairos Therapeutics is a biopharmaceutical company with a proprietary next-generation antibody-drug conjugate platform.
Kairos Therapeutics was acquired by Zymeworks in 2016.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 1
Company Info
- Founded
- 2013
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- HQ
- Vancouver, British Columbia, Canada
- Exit date
- Mar 22, 2016
- Closed
- Mar 22, 2016
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.5
- Trend (90d)
- -0.6
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Kairos Therapeutics
Loading news…
FAQs about Kairos Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.